| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |